Reevaluation of the standardized uptake value for FDG: Variations with body weight and methods for correction

被引:208
作者
Sugawara, Y [1 ]
Zasadny, KR [1 ]
Neuhoff, AW [1 ]
Wahl, RL [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Internal Med, Div Nucl Med, Ann Arbor, MI 48109 USA
关键词
breast neoplasms; PET; radionuclide studies; fluorine; radioactive; glucose; positron emission tomography (PET);
D O I
10.1148/radiology.213.2.r99nv37521
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To reevaluate the relationships between standardized uptake values (SUVs) and body weight by using positron emission tomography (PET) with 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG). MATERIALS AND METHODS: FDG; PET scanning was performed in 138 female patients with known or suspected primary breast cancers. SUVs in blood and tumor (n = 79) were calculated by using body weight (SUVbw), ideal body weight (SUVibw), lean body mass (SUVlbm), and body surface area (SUVbsa) on images obtained 50-60 minutes after the injection of FDG. RESULTS: There was a strong positive correlation between the blood SUVbw and body weight (r = 0.705, P <.001). The blood SUVibw, reduced the weight dependence but showed a negative correlation with body weight (r = -0.296, P < .001). Both the blood SUVlbm and SUVbsa eliminated the weight dependence and showed no correlation with body weight (r = -0.010, P =.904 and r = 0.106, P = .215, respectively). Although there was a wide variance in the tumor SUVbw, it showed a weak but significant positive correlation with body weight (r = 0.207, P = .033). Plots the tumor SUVlbm and SUVbsa versus body weight showed relatively flat slopes. CONCLUSION: SUVlbm and SUVbsa are weight-independent indices for FDG uptake,and SUVlbm appears to be more appropriate for quantifying FDG uptake to avoid overestimation of glucose utilization in obese patients.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 19 条
[11]   RECURRENCE OF COLORECTAL TUMORS - PET EVALUATION [J].
STRAUSS, LG ;
CLORIUS, JH ;
SCHLAG, P ;
LEHNER, B ;
KIMMIG, B ;
ENGENHART, R ;
MARINGREZ, M ;
HELUS, F ;
OBERDORFER, F ;
SCHMIDLIN, P ;
VANKAICK, G .
RADIOLOGY, 1989, 170 (02) :329-332
[12]  
STRAUSS LG, 1991, J NUCL MED, V32, P623
[13]  
Toorongian SA, 1990, INT J RAD APPL INS B, V17, P273
[14]   Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats [J].
Torizuka, T ;
Fisher, SJ ;
Brown, RS ;
Wahl, RL .
RADIOLOGY, 1998, 208 (02) :499-504
[15]   SERUM GLUCOSE - EFFECTS ON TUMOR AND NORMAL TISSUE ACCUMULATION OF 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE IN RODENTS WITH MAMMARY-CARCINOMA [J].
WAHL, RL ;
HENRY, CA ;
ETHIER, SP .
RADIOLOGY, 1992, 183 (03) :643-647
[16]   METABOLIC MONITORING OF BREAST-CANCER CHEMOHORMONOTHERAPY USING POSITRON EMISSION TOMOGRAPHY - INITIAL EVALUATION [J].
WAHL, RL ;
ZASADNY, K ;
HELVIE, M ;
HUTCHINS, GD ;
WEBER, B ;
CODY, R .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2101-2111
[17]  
WAHL RL, 1994, NUCL MED CLIN DIAGNO, P801
[18]  
Warburg O., 1931, METABOLISM TUMORS, P129
[19]   STANDARDIZED UPTAKE VALUES OF NORMAL-TISSUES AT PET WITH 2-[FLUORINE-L8]-FLUORO-2-DEOXY-D-GLUCOSE - VARIATIONS WITH BODY-WEIGHT AND A METHOD FOR CORRECTION [J].
ZASADNY, KR ;
WAHL, RL .
RADIOLOGY, 1993, 189 (03) :847-850